–
Arrowhead Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−149
FY22:
−179
FY23:
−205
FY24:
−601
FY25:
98.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−133
FY22:
−162
FY23:
−176
FY24:
−562
FY25:
165
(positive)
Change from FY21 to FY25
millions USD
FY21:
−141
FY22:
−173
FY23:
−206
FY24:
−612
FY25:
51.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−141
FY22:
−176
FY23:
−205
FY24:
−599
FY25:
−1.63
All amounts in millions USD